As of 2025-05-30, the Intrinsic Value of Kraig Biocraft Laboratories Inc (KBLB) is -0.02 USD. This KBLB valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.08 USD, the upside of Kraig Biocraft Laboratories Inc is -120.72%.
Based on its market price of 0.08 USD and our intrinsic valuation, Kraig Biocraft Laboratories Inc (KBLB) is overvalued by 120.72%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -0.02 - -0.02 | -0.02 | -120.72% |
| P/E | (0.01) - (0.02) | (0.02) | -119.8% |
| DDM - Stable | (0.03) - (0.33) | (0.18) | -324.7% |
| DDM - Multi | (0.03) - (0.24) | (0.05) | -164.9% |
| Market Cap (mil) | 84.25 |
| Beta | 0.31 |
| Outstanding shares (mil) | 1,042.65 |
| Enterprise Value (mil) | 85.47 |
| Market risk premium | 4.60% |
| Cost of Equity | 8.06% |
| Cost of Debt | 5.00% |
| WACC | 7.98% |